Sanofi Ventures announced a $625 million cash infusion to expand investments across biotech and digital health startups, reinforcing its position as a major corporate venture fund amid capital challenges in the sector. Celltrion acquired Eli Lilly’s biologics cGMP manufacturing site in New Jersey for $330 million, aiming to invest up to $1 billion for expansion. Additionally, HCAP Partners and Salt Creek Capital jointly acquired a controlling interest in Maryland-based Real Diagnostics, supporting growth in molecular laboratory testing.